This data contains information from 3727 patients and shows the performance of two IGRAs tests (T-SPOT.TB and IGRA-ELISA) used in China for screening and diagnostic Mycobacterium tuberculosis infection. The positive results were divided into four groups according with the test values, and the proportions of positives in each group were compared. The positive predictive values (PPVs) at different cutoffs for diagnostic active TB and value change trend for the two IGRAs tests were analyzed.
Specifications Table

Subject area
Biology More specific subject area Microbiology Type of data Data in this work indicates that the value change trend of the IGRA-ELISA was consistent with that of T-SPOT.TB test for the positive samples.
1. Data
The performance of the two tests for diagnostic active TB
The sensitivity and specificity for diagnostic active TB using T-SPOT.TB test were 82.9% and 78.6%, and those by IGRA-ELISA were 81.7% and 75.2%, Table 1 . The median comparison showed that the median value in active TB (ATB) group was significantly higher than that in with nonactive TB (NATB) group for the two IGRAs tests; however, neither of the assays can be applied to diagnose active TB as they cannot differentiate active TB from NATB; see Fig. 1 .
Analysis of positive test results
The positive results were divided into four groups according with the test values, and except for group 3, the proportion of positives was similarly distributed between the two tests ( Table 2 ). The PPVs of the two tests at different cutoffs for diagnostic ATB were analyzed (Fig. 2 ).
The consistency of the two tests
204 patients were tested using both the T-SPOT.TB and IGRA-ELISA. The positive, negative, and total coincidence rates between the two tests were 95.5% (84 of 88), 90.5% (105 of 116), and 92.7% (189 of 204), respectively.There was excellent consistency between the two tests with a kappa value of 0.852 (χ2 ¼ 148.64, p o 0.0001). When 84 samples that were positive to both of the two tests were analyzed, we found that the value change trend of the IGRA-ELISA was consistent with that of T-SPOT.TB test, and the two curves intersected at approximately 50 pg/mL (IGRA-ELISA) and 30 SFCs (T-SPOT.TB). 
Experimental design, materials and methods
Enrolled population
A total of 3727 patients with suspected Mycobacterium tuberculosis infection at the First Affiliated Hospital of Xi'an Jiaotong University were enrolled. Among them, 204 were tested using both the T-SPOT.TB and IGRA-ELISA, 1794 were tested using the T-SPOT.TB only, and 1729 were tested using the IGRA-ELISA only. The median age was 55 years, the majority of participants (n ¼2100 [56.3%]) were men. 244 patients were diagnosed with active TB if at least one of the following conditions were fulfilled: (i) smear-positive for acid-fast bacilli or TB PCR-positive, n ¼ 19, (ii) chest X-ray findings consistent with a radiological diagnosis of PTB, n¼ 53, (iii) granulomata or caseous necrosis observed on histopathological examination of biopsy specimens, n ¼45, or (iv) despite the absence of explicit evidence of active TB on microscopy, TB PCR, chest X-ray, or histopathology, the clinical symptoms were consistent with active TB and responded to anti-TB treatment (n ¼127). 129 and 115 of the patients underwent the T-SPOT.TB and IGRA-ELISA testing, respectively.
Performing the T-SPOT.TB and IGRA-ELISA test
Peripheral blood samples from the participants were collected in lithium-heparin-coated tubes. The T-SPOT.TB test (Oxford Immunotec Ltd., Abingdon, UK) was performed within 6 h of obtaining the blood sample. The separation and incubation of peripheral blood mononuclear cells were conducted as previously reported [1] . The IGRA-ELISA (WanTai Biological Pharmacy Enterprise Co, Ltd., Beijing, China) was performed within 2 h of obtaining the blood sample. 1 mL of blood was added to each of 3 heparinized tubes (T, N, and P tube). The tubes were incubated at 37°C for 20-24 h and were then centrifuged at 3000-5000 rpm for 10 min. The supernatant was used for the ELISA assay, performed using an automated instrument.
